Amit Mahipal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amit mahipal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amit Mahipal Today - Breaking & Trending Today

Frontline Camrelizumab/Rivoceranib Combination Shows Promise in Unresectable HCC

Amit Mahipal, MD, discusses data on camrelizumab plus rivoceranib in advanced hepatocellular carcinoma as well as the phase 3 CARES-310 trial, which is currently enrolling patients to receive the combination. ....

United States , Comunidad Autonoma De Cataluna , Amit Mahipal , Developmental Therapeutics Program , University Hospitals Seidman Cancer Center , Case Comprehensive Cancer Center , Barcelona Clinic Liver Cancer , Robust Data At Primary , Clin Cancer ,

Camrelizumab With Rivoceranib Elicits PFS and OS Benefit Over Sorafenib in Unresectable HCC

Amit Mahipal, MD, discusses clinical outcomes with camrelizumab plus rivoceranib as first-line treatment in unresectable HCC, based on data from the randomized, open-label, international phase 3 CARES-310 trial. ....

United States , Amit Mahipal , Gi Oncology Program , University Hospitals In Rochester , Case Western Reserve University , University Hospitals , Unresectable Hepatocellular Carcinoma Hcc , Phase 3 Cares 310 Trial ,

NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer, in Collaboration with Fight CRC and Pfizer

/PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced new grants awarded to improve quality. ....

Staceya Cohen , Anjee Davis , Amit Mahipal , Melissa Lumish , Vanessa Wookey , Faisal Mehmud , Case Comprehensive Cancer Center , National Comprehensive Cancer Network , Oncology Research Program , Fred Hutchinson Cancer Center , Scientific Review Committee , Fox Chase Cancer Center , Wide Initiative To Increase Access Biomarker , National Comprehensive Cancer Network Oncology Research Program , Pfizer Inc , University Hospitals Seidman Cancer Center , Colorectal Cancer , Senior Vice President , Chief Scientific Officer , Fred Hutchinson Cancer , Rapid Assessment , Molecular Profiling , Metastatic Colorectal Cancer , Liquid Biopsy , University Hospitals Seidman Cancer , Evidence Based Therapy ,

Elevar Therapeutics to Host August 10 Virtual KOL Event on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)

Elevar Therapeutics to Host August 10 Virtual KOL Event on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Mayo Clinic In Rochester , University Of Minnesota , New York , New Delhi , Memorial Sloan Kettering Cancer Center , Thomas Jefferson University , New Jersey , South Korea , Amit Mahipal , Hengrui Pharma , Ashleyr Robinson , Rosemary Ostmann , Saeho Chong , Md Memorial Sloan Kettering Cancer Center , Gastrointestinal Oncology Service , Department Of Medicine , Lifesci Advisors , American University Of Beirut Faculty Medicine , Drug Administration , Department Of Hematology , Co Ltd , University Of Connecticut Health Center , Downstate Medical Center , University Of New York , Case Western Reserve University ,

Addition of nab-paclitaxel to gemcitabine/cisplatin does not improve overall survival of patients with advanced biliary tract cancers

Adding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) time for patients with advanced biliary tract cancers, although it may provide a benefit for subsets of patients with locally advanced disease or gallbladder adenocarcinoma. ....

United States , Carol Aghajanian , Howards Hochster , Robink Kelley , Khalid Matin , Emily Henderson , Puneet Cheema , Jaykumar Thumar , Rachna Shroff , Bristol Myers Squibb , E Gabriela Chiorean , Renukav Iyer , Katherine Guthrie , Anujk Patel , Anthonyb El Khoueiry , Sloan Kettering , Philipa Philip , Aaronj Scott , Milind Javle , Lauraw Goff , Amit Mahipal , National Cancer Institute , Celgene Corporation , Siteman Cancer Center , Data Management Center , Fred Hutchinson Cancer Center ,